OptimizeRx ( NASDAQ: OPRX ) said on Monday it has appointed Steve Silvestro as the company’s new chief executive officer, effective March 10, 2025. Silvestro joined the company as chief commercial officer in April 2019, and has since served as president and, most recently, as interim CEO. Prior to joining the company, Silvestro held leadership positions at various companies including CCH® Tagetik, Prognos Health, Decision Resources Group.
Source: Press Release More on OptimizeRx OptimizeRX edges higher as holder pushes firm to explore a sale Seeking Alpha’s Quant Rating on OptimizeRx Historical earnings data for OptimizeRx Financial information for OptimizeRx.
